Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

BioXcel Ascends On $260 Mln Strategic Funding Pact, Creation Of OnkosXcel Therapeutics

BioXcel Ascends On $260 Mln Strategic Funding Pact, Creation Of OnkosXcel Therapeutics

BioXcel Therapeutics, Inc. (BTAI) shares are gaining more than 7 percent on Tuesday morning trade after the company announced strategic financing agreements with Oaktree and Qatar Investment Authority or QIA for funding support of up to $260 million for commercial activities of IGALMI sublingual film and expansion of clinical development of BXCL501 in pivotal Phase 3 program for the treatment of agitation in Alzheimer's disease.

Further, the company announced the formation of wholly-owned subsidiary OnkosXcel Therapeutics, Inc. to develop transformative medicines in oncology. The new entity would develop BXCL701, an orally administered investigational immune activator to initiate inflammation in the tumor development. In an ongoing phase 2 trial of castration-resistant prostate cancer, it will be evaluated in combination with Keytruda or pembrolizumab.

Currently, shares are trading at $15.84, up 7.21 percent from the previous close of $14.77 on a volume of 457,719. For the 52-week period, the shares have traded in a range of $14.32-$39.00 on average volume of 693,667.

19 Apr 2022

https://www.nasdaq.com/


0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies